MX2009011819A - Formulaciones de aminoacido n-halogenado. - Google Patents

Formulaciones de aminoacido n-halogenado.

Info

Publication number
MX2009011819A
MX2009011819A MX2009011819A MX2009011819A MX2009011819A MX 2009011819 A MX2009011819 A MX 2009011819A MX 2009011819 A MX2009011819 A MX 2009011819A MX 2009011819 A MX2009011819 A MX 2009011819A MX 2009011819 A MX2009011819 A MX 2009011819A
Authority
MX
Mexico
Prior art keywords
amino acid
halogenated amino
acid formulations
formulation
transfer agent
Prior art date
Application number
MX2009011819A
Other languages
English (en)
Spanish (es)
Inventor
Masood A Chowhan
Wesley Wehsin Han
L Wayne Schneider
Nissanke L Dassanayake
Original Assignee
Alcon Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Res Ltd filed Critical Alcon Res Ltd
Publication of MX2009011819A publication Critical patent/MX2009011819A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N33/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds
    • A01N33/14—Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds containing nitrogen-to-halogen bonds
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N41/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a sulfur atom bound to a hetero atom
    • A01N41/02—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a sulfur atom bound to a hetero atom containing a sulfur-to-oxygen double bond
    • A01N41/04—Sulfonic acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/02—Ammonia; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Pest Control & Pesticides (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Plant Pathology (AREA)
  • Inorganic Chemistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MX2009011819A 2007-05-01 2008-04-30 Formulaciones de aminoacido n-halogenado. MX2009011819A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91529107P 2007-05-01 2007-05-01
PCT/US2008/061942 WO2008134687A1 (en) 2007-05-01 2008-04-30 N-halogenated amino acid formulations

Publications (1)

Publication Number Publication Date
MX2009011819A true MX2009011819A (es) 2009-11-13

Family

ID=39596568

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009011819A MX2009011819A (es) 2007-05-01 2008-04-30 Formulaciones de aminoacido n-halogenado.

Country Status (16)

Country Link
US (1) US20080275123A1 (cg-RX-API-DMAC7.html)
EP (1) EP2139518A1 (cg-RX-API-DMAC7.html)
JP (1) JP2010526082A (cg-RX-API-DMAC7.html)
KR (1) KR20100017166A (cg-RX-API-DMAC7.html)
CN (1) CN101674849A (cg-RX-API-DMAC7.html)
AR (1) AR066373A1 (cg-RX-API-DMAC7.html)
AU (1) AU2008245455A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0810790A2 (cg-RX-API-DMAC7.html)
CA (1) CA2684098A1 (cg-RX-API-DMAC7.html)
CL (1) CL2008001279A1 (cg-RX-API-DMAC7.html)
MX (1) MX2009011819A (cg-RX-API-DMAC7.html)
RU (1) RU2009144292A (cg-RX-API-DMAC7.html)
TW (1) TW200902093A (cg-RX-API-DMAC7.html)
UY (1) UY31059A1 (cg-RX-API-DMAC7.html)
WO (1) WO2008134687A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200907050B (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY31058A1 (es) * 2007-05-01 2008-10-31 Alcon Res Ltd Formulaciones de aminoacido n-halogenado con compuestos antiinflamatorios
US20110151025A1 (en) 2008-04-10 2011-06-23 Novabay Pharmaceuticals, Inc. Compositions Comprising N-Halogenated or N,N-Dihalogenated Amine for Treatment and Prophylaxis of Bronchopulmonary Infections
CA2723262A1 (en) * 2008-04-15 2009-10-22 Waldemar Gottardi Compositions and devices for antisepsis and anticoagulation
JP5681630B2 (ja) * 2008-08-12 2015-03-11 ノバベイ・ファーマシューティカルズ・インコーポレイテッドＮｏｖａｂａｙ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． 抗菌性ゲル製剤
WO2010091280A1 (en) * 2009-02-06 2010-08-12 Alcon Research, Ltd. N-halogenated amino acid formulations comprising phosphine or amine oxides
CN102625558B (zh) * 2012-03-30 2014-09-03 安徽航天环境工程有限公司 带有冷却系统的等离子体加热器

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2003198C (en) * 1988-11-29 1995-03-21 Anthony J. Dziabo, Jr. Aqueous ophthalmic solutions and method for preserving same
US5320805A (en) * 1991-05-15 1994-06-14 Sterilex Corporation Methods of using a cleaner, sanitizer, disinfectant, fungicide, sporicide, chemical sterilizer
US5421818A (en) * 1993-10-18 1995-06-06 Inner Ear Medical Delivery Systems, Inc. Multi-functional inner ear treatment and diagnostic system
US6156728A (en) * 1996-11-01 2000-12-05 Genentech, Inc. Treatment of inner ear hair cells
US5968986A (en) * 1997-12-18 1999-10-19 Woodward Laboratories, Inc. Antimicrobial nail coating composition
US6759434B2 (en) * 1999-09-22 2004-07-06 B. Ron Johnson Anti-infective compositions, methods and systems for treating disordered tissue
MXPA06001898A (es) * 2003-08-18 2006-05-31 Novacal Pharmaceuticals Inc Aminoacidos n, n-dihalogenados y sus derivados.
TWI386201B (zh) * 2005-01-25 2013-02-21 Novabay Pharmaceuticals Inc Ｎ-鹵化胺基酸、ｎ，ｎ-二鹵化胺基酸與其衍生物；以及使用其之組合物與方法

Also Published As

Publication number Publication date
EP2139518A1 (en) 2010-01-06
JP2010526082A (ja) 2010-07-29
WO2008134687A1 (en) 2008-11-06
AU2008245455A1 (en) 2008-11-06
CN101674849A (zh) 2010-03-17
TW200902093A (en) 2009-01-16
KR20100017166A (ko) 2010-02-16
BRPI0810790A2 (pt) 2015-06-16
CL2008001279A1 (es) 2009-01-02
RU2009144292A (ru) 2011-06-10
US20080275123A1 (en) 2008-11-06
UY31059A1 (es) 2008-10-31
AR066373A1 (es) 2009-08-12
CA2684098A1 (en) 2008-11-06
ZA200907050B (en) 2010-12-29

Similar Documents

Publication Publication Date Title
MY155649A (en) Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease
EA201290191A1 (ru) N1-ПИРАЗОЛОСПИРОКЕТОНОВЫЕ ИНГИБИТОРЫ АЦЕТИЛ-KoA-КАРБОКСИЛАЗЫ
NZ610315A (en) Antiviral condensed heterocyclic compounds
BR112012033117A2 (pt) pirazolo[1,5-a]pirimidinas como agentes antivirais
MX2013002584A (es) Compuesto de pirazoloquinolina.
EA017091B9 (ru) Фумаратная соль (альфа s, бета r)-6-бром-альфа-[2-(диметиламино)этил]-2-метокси-альфа-1-нафталенил-бета-фенил-3-хинолинэтанола
WO2008054454A3 (en) Nitrogen-containing heterocycle derivatives, pharmaceutical compositions, and methods of use thereof as antiviral agents
WO2010111640A3 (en) Anti-influenza formulations and methods
MX337614B (es) Tratamiento de lupus nefritis usando laquinimod.
MX2012003324A (es) Compuesto de glicina.
MX2014003408A (es) N-(3-(2-amino-6,6-difluor-4,4a,5,6,7,7a-hexahidro-ciclopenta-[e][ 1,3]oxazin-4-il)-fenil)-amidas como inhibidores de la beta-secretasa 1 (bace1).
WO2010107807A3 (en) Compounds for treating inflammation and pain
WO2008143649A3 (en) Novel oxazolidinone compounds as antiinfective agents
MX2009011819A (es) Formulaciones de aminoacido n-halogenado.
WO2006078424A3 (en) Polyherbal compositions and methods for treating viral infections
MX362830B (es) Agente terapeutico o profilactico para enfermedades del tracto biliar.
UA96794C2 (ru) Глюкокортикоиды, способ их применения, способ лечения и фармацевтическая композиция на их основе
MX2009011818A (es) Formulaciones de aminoacido n-halogenado con compuestos anti-inflamatorios.
TN2014000031A1 (en) Use of organic compound for the treatment of noonan syndrome
WO2011153458A3 (en) Compositions and methods for inhibition of or treatment of dengue virus infection
MX2009011817A (es) Formulaciones de aminoacido n-halogenado que contienen acido alifatico.
WO2007144889A3 (en) Treatment of neurofibromatosis
MX2009003930A (es) Novedoso cristal de (s)-(+)-2-(2-clorofenil)-2-hidroxi-etil carbamato.
UA97044C2 (ru) Средство противовирусной и иммуностимулирующей активности, способ получения средства противовирусной и иммуностимулирующей активности, способ профилактики и лечения инфекционных болезней
TN2010000584A1 (en) Paediatric compositions for treating multiple scleoris